NT-proBNP and changes in cognition and global brain structure: The Rotterdam Study
- PMID: 37165557
- DOI: 10.1111/ene.15859
NT-proBNP and changes in cognition and global brain structure: The Rotterdam Study
Abstract
Objective: To investigate the association between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and changes in cognition and global brain structure.
Methods: In the Rotterdam Study, baseline NT-proBNP was assessed at baseline from 1997 to 2008. Between 1997 and 2016, participants without dementia or stroke at baseline (n = 9566) had repeated cognitive tests (every 3-6 years) for global cognitive function, executive cognitive function, fine manual dexterity, and memory. Magnetic resonance imaging of the brain was performed repeatedly at re-examination visits between 2005 and 2015 for 2607 participants to obtain brain volumes, focal brain lesions, and white matter microstructural integrity as measures of brain structure.
Results: Among 9566 participants (mean age 65.1 ± 9.8 years), 5444 (56.9%) were women, and repeated measures of cognition were performed during a median follow-up time of 5.5 (range 1.1-17.9) years, of whom 2607 participants completed at least one brain imaging scan. Higher levels of NT-proBNP were associated with a faster decline of scores in the global cognitive function (p value = 0.003) and the Word-Fluency test (p value = 0.003) but were not related to a steeper deterioration in brain volumes, global fractional anisotropy, and mean diffusivity, as indicators of white matter microstructural integrity, or focal brain lesions.
Conclusions: Higher baseline NT-proBNP levels were associated with a faster decline in cognition; however, no association with global brain structure was found.
Keywords: MRI; NT-proBNP, change; brain structure; cognition; repeated measurements.
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
References
REFERENCES
-
- Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357-2368.
-
- Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975.
-
- van der Velpen IF, Yancy CW, Sorond FA, Sabayan B. Impaired cardiac function and cognitive brain aging. Can J Cardiol. 2017;33:1587-1596.
-
- Ritz K, van Buchem MA, Daemen MJ. The heart-brain connection: mechanistic insights and models. Neth Heart J. 2013;21:55-57.
-
- Alves TC, Busatto GF. Regional cerebral blood flow reductions, heart failure and Alzheimer's disease. Neurol Res. 2006;28:579-587.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
